|
|
Line 3: |
Line 3: |
| <StructureSection load='6o41' size='340' side='right'caption='[[6o41]], [[Resolution|resolution]] 2.46Å' scene=''> | | <StructureSection load='6o41' size='340' side='right'caption='[[6o41]], [[Resolution|resolution]] 2.46Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[6o41]] is a 9 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human] and [http://en.wikipedia.org/wiki/Strsg Strsg]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6O41 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6O41 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6o41]] is a 9 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Streptococcus_sp._'group_G' Streptococcus sp. 'group G']. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6O41 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6O41 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.465Å</td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6o3d|6o3d]], [[6o3g|6o3g]], [[6o3j|6o3j]], [[6o3k|6o3k]], [[6o3l|6o3l]], [[6o3u|6o3u]], [[6o42|6o42]]</td></tr>
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">spg ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1320 STRSG])</td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6o41 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6o41 OCA], [https://pdbe.org/6o41 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6o41 RCSB], [https://www.ebi.ac.uk/pdbsum/6o41 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6o41 ProSAT]</span></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6o41 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6o41 OCA], [http://pdbe.org/6o41 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6o41 RCSB], [http://www.ebi.ac.uk/pdbsum/6o41 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6o41 ProSAT]</span></td></tr> | + | |
| </table> | | </table> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/SPG2_STRSG SPG2_STRSG] |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 18: |
Line 19: |
| </div> | | </div> |
| <div class="pdbe-citations 6o41" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 6o41" style="background-color:#fffaf0;"></div> |
| + | |
| + | ==See Also== |
| + | *[[Antibody 3D structures|Antibody 3D structures]] |
| + | *[[Protein G|Protein G]] |
| == References == | | == References == |
| <references/> | | <references/> |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Human]] | + | [[Category: Homo sapiens]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Strsg]] | + | [[Category: Streptococcus sp. 'group G']] |
- | [[Category: Irimia, A]] | + | [[Category: Irimia A]] |
- | [[Category: Wilson, I A]] | + | [[Category: Wilson IA]] |
- | [[Category: Broadly neutralising hiv-1 antibody]]
| + | |
- | [[Category: Germline pgzl1 anti hiv-1]]
| + | |
- | [[Category: Gp41 mper]]
| + | |
- | [[Category: Immune system]]
| + | |
- | [[Category: Membrane lipid]]
| + | |
| Structural highlights
Function
SPG2_STRSG
Publication Abstract from PubMed
The membrane-proximal external region (MPER) of HIV-1 envelope glycoprotein (Env) can be targeted by neutralizing antibodies of exceptional breadth. MPER antibodies usually have long, hydrophobic CDRH3s, lack activity as inferred germline precursors, are often from the minor IgG3 subclass, and some are polyreactive, such as 4E10. Here we describe an MPER broadly neutralizing antibody from the major IgG1 subclass, PGZL1, which shares germline V/D-region genes with 4E10, has a shorter CDRH3, and is less polyreactive. A recombinant sublineage variant pan-neutralizes a 130-isolate panel at 1.4 mug/ml (IC50). Notably, a germline revertant with mature CDR3s neutralizes 12% of viruses and still binds MPER after DJ reversion. Crystal structures of lipid-bound PGZL1 variants and cryo-EM reconstruction of an Env-PGZL1 complex reveal how these antibodies recognize MPER and viral membrane. Discovery of common genetic and structural elements among MPER antibodies from different patients suggests that such antibodies could be elicited using carefully designed immunogens.
An MPER antibody neutralizes HIV-1 using germline features shared among donors.,Zhang L, Irimia A, He L, Landais E, Rantalainen K, Leaman DP, Vollbrecht T, Stano A, Sands DI, Kim AS, Poignard P, Burton DR, Murrell B, Ward AB, Zhu J, Wilson IA, Zwick MB Nat Commun. 2019 Nov 26;10(1):5389. doi: 10.1038/s41467-019-12973-1. PMID:31772165[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Zhang L, Irimia A, He L, Landais E, Rantalainen K, Leaman DP, Vollbrecht T, Stano A, Sands DI, Kim AS, Poignard P, Burton DR, Murrell B, Ward AB, Zhu J, Wilson IA, Zwick MB. An MPER antibody neutralizes HIV-1 using germline features shared among donors. Nat Commun. 2019 Nov 26;10(1):5389. doi: 10.1038/s41467-019-12973-1. PMID:31772165 doi:http://dx.doi.org/10.1038/s41467-019-12973-1
|